According to Biotest
's latest financial reports the company's current revenue (TTM ) is โน66.91 Billion. In 2023 the company made a revenue of โน61.72 Billion an increase over the revenue in the year 2022 that were of โน45.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | โน64.44 B | 4.41% |
2023 | โน61.72 B | 36.83% |
2022 | โน45.11 B | 1.05% |
2021 | โน44.64 B | 8.47% |
2020 | โน41.15 B | 22.98% |
2019 | โน33.46 B | 1.74% |
2018 | โน32.89 B | 72.19% |
2017 | โน19.10 B | -50.42% |
2016 | โน38.53 B | -11.01% |
2015 | โน43.30 B | -9.63% |
2014 | โน47.91 B | 16.45% |
2013 | โน41.14 B | 31.17% |
2012 | โน31.36 B | 1.89% |
2011 | โน30.78 B | 38.75% |
2010 | โน22.18 B | -22.8% |
2009 | โน28.73 B |